Monday, 8 March 2010
Are You A Tax Cheat?
Tuesday, 16 February 2010
Version 1.3 of the eLert Gadget Firefox add-on is now ready
Thursday, 21 January 2010
\"We woz brung up propur\"
Sunday, 15 February 2009
TOP 5 OPTIONS FOR COLON CLEANSING TREATMENTS
This waste material that is residual in the colon can result in the toxic poisoning of the system as a result of the reabsorption of the waste materials. When this occurs there is a need for colon cleansing which simply is the cleaning of the large and small intestine of any waste materials that has been lodged there as a result of the bowel's inability to expel it.
Colon cleansing should be regular event in any one's life given the fact that we all pas feces which can have remnants lodged in our bodies. This is important because it has been shown that the average adult has between five and forty pounds of waste materials deposited in the bowel. Therefore, you see the need for a regular colon cleansing exercise.
However, colon cleansing comes in various methods:
1. The use of Enemas
2. The use of Laxatives
3. Using oxygen-based cleansers
4. Colon hydrotherapy
5. Herbal supplements
As with everything in life, these techniques have both got their pluses and minuses. So, we'll take a brief look at each of the methods and see how much benefit they each give.
1. Enemas.
Enemas have been known to have been in existence for thousands if years. History has shown it was used in Egypt as a form of treatment for digestive maladies and disorders. Enemas vary –water, clay, and coffee-and so do the results stemming from its use. Most times, enemas just get rid of waste that is deposited and impacting the lower colon. However, enemas cannot function as a melting agent that will melt away all the waste materials. So its use is in a away limited. It is very effective in rectum emptying. The reason some people do not also like using enemas is because they do not like the idea of inserting any form of enema in the rectum.
Note: Check out Part 2 tomorrow for the continuation of the article.
Friday, 19 September 2008
BLOCKING ENZYME COULD HELP IN RARE BLOOD CANCER
An enzyme that fights some kinds of cancers may foster the growth of a rare type of leukemia that affects babies, U.S. researchers said on Wednesday in a finding that may lead to new drugs for the hard-to-treat cancer.
They said drugs that blocked the enzyme glycogen synthase kinase, or GSK3, helped mice with mixed-lineage leukemia, or MLL, live far longer than untreated mice.
The finding is a surprise because prior studies have found GSK3 helped suppress unchecked cell growth in other cancers.
"GSK3 has never been implicated in promoting cancer," said Dr. Michael Cleary of Stanford University in California, whose research appears in the journal Nature.
Cleary's team found that blocking GSK3 fights leukemias caused by mutations in the MLL gene, which accounts for 5 percent to 10 percent of child and adult leukemias and more than three-quarters of leukemias diagnosed in infants.
Cleary said only a few hundred people in the United States get MLL each year, but when babies get leukemia, they tend to get this form, although it is not clear why.
While most leukemias get their start in either lymph nodes or bone marrow, MLL cancer cells can originate from both.
"These patients don't typically respond well to chemotherapy. There is a real need for better treatments," Cleary said in a telephone interview.
His team first got a hint that blocking GSK3 might fight MLL through routine screening tests in the lab.
The researchers gave the mice with MLL lithium, a drug used to treat bipolar disease in humans.
"It is not the best GSK3 inhibitor, but it is one that could be administered long-term in mice," Cleary said.
Mice treated with the lithium lived significantly longer than the untreated mice. Cleary's team also used a different GSK3 inhibitor in MLL cells and found it stopped them from growing.
"I think where we need to go in the future is to come up with better inhibitors that can be administered long-term," Cleary said.
That may come through research of the drug in other diseases. Cleary said drug companies are developing GSK3 inhibitors as treatments for diabetes and Alzheimer's disease.Monday, 8 September 2008
Saturday, 6 September 2008
BREATHING DISORDER PUTS BLACKS AT HIGH CANCER RISK.
They said the high risk for blacks with chronic obstructive pulmonary disease highlights the need for better risk assessment tools that take race and ethnicity into account.
'The one-size-fits-all risk prediction clearly does not work,' Carol Etzel of the University of Texas M.D. Anderson Cancer Center, whose report appears in the journal Cancer Prevention Research, said in a statement.
Etzel's team developed the risk assessment tool for African Americans to help doctors better predict a patient's specific risk for lung cancer.
They analyzed data from 491 African Americans with lung cancer and 497 African Americans without lung cancer to look for risk factors. They compared these with existing risk models for whites.
The new model found black men with a prior history of COPD had a more than sixfold increased risk of lung cancer, on par with someone who is actively smoking."